Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and Pathogenesis. Trends Immunol. 2020;41:1100–15.
Article CAS PubMed PubMed Central Google Scholar
WHO COVID-19. Dashboard [Internet]. June 01 2023. Geneva: World Health Organization; [cited June 01 2023]. https://covid19.who.int/
Modes ME, et al. Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B.1.617.2 (Delta) and B.1.1.529 (omicron) variant predominance - one hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:217–23.
Article CAS PubMed PubMed Central Google Scholar
Rzymski P, Kasianchuk N, Sikora D, Poniedziałek B. COVID-19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022. J Med Virol. 2023;95:e28131.
Article CAS PubMed Google Scholar
Mhawish H, et al. Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: a prospective observational study. Annals Med Surg. 2021;71:102951.
Moghadas SM, et al. The impact of vaccination on Coronavirus Disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis. 2021;73:2257–64.
Article CAS PubMed PubMed Central Google Scholar
Covid C, et al. COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1–April 30, 2021. Morb Mortal Wkly Rep. 2021;70:792.
Grasselli G et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020.
Kartsonaki C, et al. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. Int J Epidemiol. 2023;52:355–76.
Article PubMed PubMed Central Google Scholar
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–42.
Article CAS PubMed Google Scholar
Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141–54.
Article CAS PubMed Google Scholar
Zhou Y, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis. Int J Infect Dis. 2020;99:47–56.
Article CAS PubMed PubMed Central Google Scholar
Jain V, Yuan J-M. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020;65:533–46.
Ahlström B, et al. The Swedish covid-19 intensive care cohort: risk factors of ICU admission and ICU mortality. Acta Anaesthesiol Scand. 2021;65:525–33.
Article PubMed PubMed Central Google Scholar
Bart GP, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11:e044640.
Del Valle DM, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636–43.
Article PubMed PubMed Central Google Scholar
Han H, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infections. 2020;9:1123–30.
Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biology. 2020;10:200160.
Article CAS PubMed PubMed Central Google Scholar
Yang L, et al. COVID-19: immunopathogenesis and immunotherapeutics. Signal Transduct Target Therapy. 2020;5:128.
Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 2020;133:155151.
Article CAS PubMed PubMed Central Google Scholar
Fraser DD, et al. Novel outcome biomarkers identified with targeted proteomic analyses of plasma from critically ill coronavirus Disease 2019 patients. Crit Care Explor. 2020;2:e0189.
Article PubMed PubMed Central Google Scholar
Fraser DD, et al. Inflammation profiling of critically ill coronavirus Disease 2019 patients. Crit Care Explor. 2020;2:e0144.
Article PubMed PubMed Central Google Scholar
Fraser DD, et al. Endothelial Injury and Glycocalyx Degradation in critically ill coronavirus Disease 2019 patients: implications for microvascular platelet aggregation. Crit care Explorations. 2020;2:e0194–0194.
Gorog DA, et al. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 thrombosis biomarkers Colloquium. Nat Reviews Cardiol. 2022;19:475–95.
Yao Y, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8:49.
Article PubMed PubMed Central Google Scholar
Cabrera-Garcia D, et al. Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients. Int J Hematol. 2022;116:937–46.
Article CAS PubMed PubMed Central Google Scholar
Fraser DD, et al. Detection and profiling of human coronavirus immunoglobulins in critically ill coronavirus Disease 2019 patients. Crit Care Explor. 2021;3:e0369.
Article PubMed PubMed Central Google Scholar
Fraser DD, et al. Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens. Ann Clin Lab Sci. 2022;52:651–62.
Fraser DD, et al. Critically ill COVID-19 patients exhibit Anti-SARS-CoV-2 serological responses. Pathophysiology. 2021;28:212–23.
Article PubMed PubMed Central Google Scholar
Iosef C, et al. COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management. J Cell Mol Med. 2023;27:141–57.
Article CAS PubMed Google Scholar
Singer M, et al. The Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.
Article CAS PubMed PubMed Central Google Scholar
CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel [Internet]. https://www.fda.gov/media/134922/download
NIH HRPP. POLICY: Guidelines for Limits of Blood Drawn for Research Purposes in the Clinical Center. M95-9 (rev.) June 5. 2009.
Brisson AR, Matsui D, Rieder MJ, Fraser DD. Translational research in pediatrics: tissue sampling and biobanking. Pediatrics. 2012;129:153–62.
Gillio-Meina C, Cepinskas G, Cecchini EL, Fraser DD. Translational research in pediatrics II: blood collection, processing, shipping, and storage. Pediatrics. 2013;131:754–66.
Priestap F, Kao R, Martin CM. External validation of a prognostic model for intensive care unit mortality: a retrospective study using the Ontario critical care information system. Can J Anaesth. 2020.
Kursa MB, Rudnicki W R. Feature Selection with the Boruta Package. Journal of Statistical Software. 2010;36(11):1–13.
Tang C, Garreau D, and von Luxburg U. When do random forests fail? In: NeurIPS. 2018;2987–97.
Van der Maaten L, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008;9.
Jambu M. Chap. 10 - classification of individuals–variables data sets. In: Jambu M, editor. Exploratory and Multivariate Data Analysis. Boston: Academic; 1991;305–405.
Pedregosa F, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825–30.
Bateman A, et al. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480–9.
Zhang Y, Zhang Y, Qi P, Manning CD, Langlotz CP. Biomedical and clinical English model packages for the Stanza Python NLP library. J Am Med Inform Assoc. 2021;28:1892–9.
Article PubMed PubMed Central Google Scholar
Qi P, Zhang Y, Zhang Y, Bolton J, Manning CD. Stanza: A Python natural language processing toolkit for many human languages. arXiv preprint arXiv:2003.07082. 2020.
Honnibal M, Montani I, Van Landeghem S, Boyd A. spaCy: Industrial-strength Natural Language Processing in Python. 2020.
Gupta S, et al. Factors Associated with Death in critically ill patients with Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020;180:1436–47.
Article CAS PubMed Google Scholar
di Flora DC et al. Analysis of Plasma Proteins Involved in Inflammation, Immune Response/Complement System, and Blood Coagulation upon Admission of COVID-19 Patients to Hospital May Help to Predict the Prognosis of the Disease. Cells. 2023;12.
Völlmy F et al. A serum proteome signature to predict mortality in severe COVID-19 patients. Life Sci Alliance. 2021;4.
Bhatraju PK et al. Covid-19 in critically ill patients in the Seattle Region - Case Series. N Engl J Med. 2020.
Gutmann C, et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun. 2021;12:3406.
留言 (0)